At Highland Ophthalmology Associates, we are offering the latest innovative advancement in Glaucoma care, Voyager™ DSLT (Direct Selective Laser Trabeculoplasty. This new technology allows us to provide a highly effective and more efficient treatment for our patients with glaucoma and ocular hypertension.
Why We Are Introducing Voyager™ DSLT
Voyager™ DSLT is a non-contact laser treatment designed to lower intraocular pressure. It offers several significant advantages over traditional methods:
-
Exceptional Patient Comfort: The procedure is designed for a "gonio-free" experience, meaning no lens is placed on your eye during treatment.
-
Rapid Treatment: The laser delivery itself is remarkably quick, lasting only 2.4 seconds.
-
Fully Automated: The device uses advanced technology to track your natural eye movement, ensuring a precise and automated experience.
-
Proven Results: Clinical trials demonstrated that DSLT provides effective eye pressure lowering that is sustained for 12 months after a single treatment.
-
Reduced Dependency on Drops: Many patients find they can reduce their daily medication burden. In clinical studies, 70% of patients remained medication-free 12 months after their procedure.
What to Expect During Your Visit
If we determine that DSLT is right for you, the process is straightforward and efficient:
-
Preparation: You will receive standard eye drops.
-
Comfort: Your eye will be held open with a gentle lid speculum to help prevent blinking during the brief procedure.
-
Treatment: You will look at a fixed light while the device tracks your eye and completes the treatment in seconds.
Patient Satisfaction
Our patients' experiences are our top priority. Voyager™ DSLT has an extremely high patient satisfaction rate, with 96% satisfaction reported at six months. Additionally, 92.5% of patients indicated they would recommend this treatment to a friend with glaucoma.
Important Product Information
Indication: Voyager™ DSLT is indicated for use in Selective Laser Trabeculoplasty (SLT) to treat patients with glaucoma or ocular hypertension.
Safety Profile: DSLT has an excellent safety profile. Short-term side effects may include mild discomfort, redness, blurry vision, or sensitivity to light. The most common side effect is a small, self-resolving red spot on the white part of the eye (punctate sub-conjunctival hemorrhage).
Contraindications: This treatment is not recommended for patients who cannot fixate their head or eyes, those with pupils that cannot constrict to 4 mm or less, or patients with certain glaucoma implants.
Is it time to upgrade your glaucoma treatment plan? Contact Highland Ophthalmology Associates today to schedule a consultation and see if Voyager™ DSLT is right for you.